/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision...
/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision...
/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision...
Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster...
/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision...
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.56%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.26%. Stocks on Tuesday...
Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall
The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. The broader market is higher...
The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.78%. Stocks this morning...
June S&P 500 E-Mini futures (ESM24) are trending down -0.44% this morning as investors awaited the start of the Federal Reserve’s two-day policy meeting while also gearing up for the release of fresh...